Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Deloitte
Accenture
Covington
Johnson and Johnson

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 9,079,953

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,079,953
Title:Anti-VEGF antibodies and their uses
Abstract: The present disclosure relates to antibodies directed to vascular endothelial growth factor (\"VEGF\") and uses of such antibodies, for example to treat diseases associated with the activity and/or overproduction of VEGF.
Inventor(s): Harding; Fiona A. (Santa Clara, CA), Akamatsu; Yoshiko (Palo Alto, CA), DuBridge; Robert B. (Belmont, CA), Powers; David B. (Fairfax, CA)
Assignee: AbbVie Biotherapeutics Inc. (Redwood City, CA)
Application Number:12/817,800
Patent Claims:see list of patent claims

Details for Patent 9,079,953

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech LUCENTIS ranibizumab INJECTABLE; INJECTION 125156 001 2006-06-30 ➤ Try a Free Trial AbbVie Biotherapeutics Inc. (Redwood City, CA) ➤ Try a Free Trial RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Try a Free Trial AbbVie Biotherapeutics Inc. (Redwood City, CA) ➤ Try a Free Trial RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Try a Free Trial AbbVie Biotherapeutics Inc. (Redwood City, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,079,953

Country Patent Number Publication Date
South Africa 201109098 Aug 29, 2012
World Intellectual Property Organization (WIPO) 2010148223 Dec 23, 2010
World Intellectual Property Organization (WIPO) 2010148223 Mar 03, 2011
United States of America 2010322931 Dec 23, 2010
Ukraine 104626 Feb 25, 2014
Taiwan 201103561 Feb 01, 2011
Taiwan I510248 Dec 01, 2015
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Accenture
Boehringer Ingelheim
Federal Trade Commission
Cipla
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.